Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Table 2

BAP1 status in histology and cytology specimens.

BAP1 status	Surgical		Cytology
	Negative	Positive	Negative	Positive
Total	47 (58%)	34 (42%)	34 (59%)	23 (41%)
Gender
Male	39 (62%)	24 (38%)	30 (65%)	16 (35%)
Female	8 (44%)	10 (56%)	4 (36%)	7 (64%)
Age
Median (range)	74 (53–92)	74 (35–91)	74 (53–92)	74 (35–91)
Subtype
Epithelioid	35 (61%)	22 (39%)	27 (63%)	16 (37%)
Biphasic	8 (62%)	5 (38%)	4 (57%)	3 (43%)
Sarcomatoid	4 (36%)	7 (64%)	3 (43%)	4 (57%)
Location
Pleural	47 (59%)	33 (41%)	34 (61%)	22 (39%)
Peritoneal	0	1 (100%)	0	1 (100%)